Log in to save to my catalogue

Pathophysiology and Therapeutics of Thoracic Aortic Aneurysm in Marfan Syndrome

Pathophysiology and Therapeutics of Thoracic Aortic Aneurysm in Marfan Syndrome

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7b09de9343b048efa754861bc7738b09

Pathophysiology and Therapeutics of Thoracic Aortic Aneurysm in Marfan Syndrome

About this item

Full title

Pathophysiology and Therapeutics of Thoracic Aortic Aneurysm in Marfan Syndrome

Publisher

Switzerland: MDPI AG

Journal title

Biomolecules (Basel, Switzerland), 2022-01, Vol.12 (1), p.128

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

About 20% of individuals afflicted with thoracic aortic disease have single-gene mutations that predispose the vessel to aneurysm formation and/or acute aortic dissection often without associated syndromic features. One widely studied exception is Marfan syndrome (MFS) in which mutations in the extracellular protein fibrillin-1 cause additional abn...

Alternative Titles

Full title

Pathophysiology and Therapeutics of Thoracic Aortic Aneurysm in Marfan Syndrome

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_7b09de9343b048efa754861bc7738b09

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7b09de9343b048efa754861bc7738b09

Other Identifiers

ISSN

2218-273X

E-ISSN

2218-273X

DOI

10.3390/biom12010128

How to access this item